COMPOSITION COMPRENANT DE LA N-ACÉTYLCYSTÉINE ET DES BACTÉRIES PROBIOTIQUES POUVANT RÉTABLIR LE PROPRE EFFET DE BARRIÈRE DE L'ESTOMAC QUI EST PERDU PENDANT LE TRAITEMENT DE L'HYPERACIDITÉ GASTRIQUE À L'AIDE D'INHIBITEURS DE LA POMPE À PROTONS
The present invention refers to a composition comprising N-acetylcysteine and/or lysozyme； or N-acetylcysteine and microencapsulated gastroprotected lysozyme with probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the stomach's own barrier effect, which is lost during the pharmacological treatment of gastric hyperacidity, and of minimising the secondary effects due to said pharmacological treatment.
